Chemoinformaics analysis of 2,3-Dihydroxypropyl acetate
Molecular Weight | 134.131 | nRot | 3 |
Heavy Atom Molecular Weight | 124.051 | nRig | 1 |
Exact Molecular Weight | 134.058 | nRing | 0 |
Solubility: LogS | 0.653 | nHRing | 0 |
Solubility: LogP | -0.896 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 18.2259 |
nHD | 2 | BPOL | 12.6361 |
QED | 0.481 |
Synth | 2.631 |
Natural Product Likeliness | 1.891 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.037 |
HIA | 0.207 |
CACO-2 | -4.972 |
MDCK | 0.0045207 |
BBB | 0.232 |
PPB | 0.126227 |
VDSS | 0.542 |
FU | 0.878178 |
CYP1A2-inh | 0.022 |
CYP1A2-sub | 0.072 |
CYP2c19-inh | 0.016 |
CYP2c19-sub | 0.445 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.152 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.163 |
CYP3a4-inh | 0.008 |
CYP3a4-sub | 0.104 |
CL | 3.403 |
T12 | 0.885 |
hERG | 0.032 |
Ames | 0.306 |
ROA | 0.015 |
SkinSen | 0.101 |
Carcinogencity | 0.05 |
EI | 0.267 |
Respiratory | 0.017 |
NR-Aromatase | 0.003 |
Antiviral | No |
Prediction | 0.957031 |